Literature DB >> 6867252

Surveillance and control of infectious diseases: progress toward the 1990 objectives.

W R Dowdle.   

Abstract

Great progress has been made in the United States in reducing infectious disease mortality. However, infectious diseases remain the greatest cause of morbidity in this country. Newer infectious diseases or agents have been recognized, but newer tools for surveillance and control have also been made available. Specific objectives for the reduction of infectious diseases by 1990 have been set by the Public Health Service. The opportunities appear to be good for achieving by 1990 objectives for nosocomial infections, Legionnaires' disease, tuberculosis, and surveillance and control of infectious diseases. Achievement of the 1990 objectives for hepatitis B, pneumococcal pneumonia, and bacterial meningitis, however, will require both scientific advances and additional resources.

Entities:  

Mesh:

Year:  1983        PMID: 6867252      PMCID: PMC1424442     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Human infections: economic implications and prevention.

Authors:  J V Bennett
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

2.  Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humans.

Authors:  B K Nottay; O M Kew; M H Hatch; J T Heyward; J F Obijeski
Journal:  Virology       Date:  1981-01-30       Impact factor: 3.616

3.  The emergence of infection surveillance and control programs in US hospitals: an assessment, 1976.

Authors:  R W Haley; R H Shachtman
Journal:  Am J Epidemiol       Date:  1980-05       Impact factor: 4.897

4.  Preliminary results of six-month regimens studied in the United States and in Poland.

Authors:  D Snider; M Long; M Zierski; J Rogowski; E Bek
Journal:  Chest       Date:  1981-12       Impact factor: 9.410

5.  Epidemiology of hepatitis B in two Alaska communities.

Authors:  D H Barrett; J M Burks; B McMahon; S Elliott; K R Berquist; T R Bender; J E Maynard
Journal:  Am J Epidemiol       Date:  1977-02       Impact factor: 4.897

6.  The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design.

Authors:  R W Haley; D Quade; H E Freeman; J V Bennett
Journal:  Am J Epidemiol       Date:  1980-05       Impact factor: 4.897

7.  The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men.

Authors:  D P Francis; S C Hadler; S E Thompson; J E Maynard; D G Ostrow; N Altman; E H Braff; P O'Malley; D Hawkins; F N Judson; K Penley; T Nylund; G Christie; F Meyers; J N Moore; A Gardner; I L Doto; J H Miller; G H Reynolds; B L Murphy; C A Schable; B T Clark; J W Curran; A G Redeker
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

8.  Primary hepatocellular carcinoma in Alaskan natives, 1969-1979.

Authors:  W L Heyward; A P Lanier; T R Bender; H H Hardison; P H Dohan; B J McMahon; D P Francis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

9.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

  9 in total
  1 in total

1.  Benefit-cost analysis of active surveillance of primary care physicians for hepatitis A.

Authors:  M W Hinds; J W Skaggs; G H Bergeisen
Journal:  Am J Public Health       Date:  1985-02       Impact factor: 9.308

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.